These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 32096839)
21. Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction. García-Méndez RC; Almeida-Gutierrez E; Serrano-Cuevas L; Sánchez-Díaz JS; Rosas-Peralta M; Ortega-Ramirez JA; Palomo-Villada JA; Isordia-Salas I; Alonso-Bravo RM; Borrayo-Sanchez G Arch Med Res; 2018 Nov; 49(8):620-629. PubMed ID: 30446246 [TBL] [Abstract][Full Text] [Related]
22. Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study). Ricottini E; Madonna R; Grieco D; Zoccoli A; Stampachiacchiere B; Patti G; Tonini G; De Caterina R; Di Sciascio G Am J Cardiol; 2016 Jan; 117(2):165-71. PubMed ID: 26743348 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related]
24. What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome? Goriacko P; Andersen M; Fazylov R; Plakogiannis R J Pharm Pract; 2015 Dec; 28(6):555-60. PubMed ID: 25107416 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy. Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome. Liu Z; Hao H; Yin C; Chu Y; Li J; Xu D Oncotarget; 2017 Jun; 8(25):41582-41589. PubMed ID: 28177908 [TBL] [Abstract][Full Text] [Related]
27. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials. Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831 [TBL] [Abstract][Full Text] [Related]
35. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials. Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891 [TBL] [Abstract][Full Text] [Related]
36. Utility of early high dose statins in acute coronary syndrome. Dougherty PJ; Arora RR Am J Ther; 2012 Sep; 19(5):369-76. PubMed ID: 22964560 [TBL] [Abstract][Full Text] [Related]
37. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923 [TBL] [Abstract][Full Text] [Related]
38. Prescription of statins after acute coronary syndrome; a single-centre observational study. Mahmood MM; Nawaz MJ J Pak Med Assoc; 2023 Mar; 73(3):646-649. PubMed ID: 36932772 [TBL] [Abstract][Full Text] [Related]
39. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial. Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599 [TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention. Wu H; Li D; Fang M; Han H; Wang H J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]